ABILIFY MAINTENA
OTSUKA PHARMACEUTICAL CO LTD
Quick answers
Is there a shortage of ABILIFY MAINTENA in Canada?
No. There is no current shortage of ABILIFY MAINTENA 300MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
ABILIFY MAINTENA
OTSUKA PHARMACEUTICAL CO LTD
AG-ARIPIPRAZOLE
ANGITA PHARMA INC.
AURO-ARIPIPRAZOLE
AURO PHARMA INC
PMS-ARIPIPRAZOLE
PHARMASCIENCE INC
SANDOZ ARIPIPRAZOLE
SANDOZ CANADA INCORPORATED
ABILIFY
OTSUKA PHARMACEUTICAL CO LTD
DIN
02420864
Strength
300MG
Dosage Form
Powder For Suspension (Sustained-Release
Route
Intramuscular
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from OTSUKA PHARMACEUTICAL CO LTD
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
15MG · DIN 02322404
10MG · DIN 02322390
2MG · DIN 02322374
30MG · DIN 02322455
20MG · DIN 02322412
5MG · DIN 02322382
960MG · DIN 02554577
720MG · DIN 02554569
400MG · DIN 02420872
60MG · DIN 02240602
DIN 02437511
DIN 02437538